Anticancer effects of fraction isolated from fruiting bodies of Chaga medicinal mushroom, Inonotus obliquus (Pers.:Fr.) Pilát (Aphyllophoromycetideae): In vitro studies

International Journal of Medicinal Mushrooms

Volumn 13, Issue 2, 2011, Pages 131-143

  Lemieszek, Marta Kinga ^a   Langner, Ewa ^a,b   Kaczor, Józef ^b   Kandefer Szerszeń, Martyna ^b   Sanecka, Bozena ^c   Mazurkiewicz, Witold ^c   Rzeski, Wojciech ^a,b  

^a INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^b MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^c RZESZOW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Anticancer activity; Chaga mushroom; Colon adenocarcinoma; Human lung carcinoma; Human skin fibroblasts; Inonotus obliquus; Medicinal mushrooms

Indexed keywords

ANTINEOPLASTIC AGENT; HERBACEOUS AGENT;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL CULTURE; CELL DEATH; CELL MOTILITY; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FRUIT; FUNGUS ISOLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INONOTUS OBLIQUUS; LIVER CELL; MACROGLIA; MOUSE; MUSHROOM; NERVE CELL; NONHUMAN; OLIGODENDROGLIA; PILAT; RAT; SKIN FIBROBLAST; TOXICITY TESTING; TUMOR CELL;

AGARICALES; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOLOGICAL AGENTS; CATTLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FRUITING BODIES, FUNGAL; HUMANS; MICE; RATS;

BASIDIOMYCOTA; BOVINAE; HYMENOCHAETACEAE; INONOTUS OBLIQUUS; RATTUS;

EID: 79960060944     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v13.i2.50     Document Type: Article

References (37)

1. Cha JY, Jeon BS, Moon J, Yoo JH, Cho YS. Cytotoxic effect of Inonotus obliquus composition in HCT-15 human colon cancer cells and AGS gastric cancer cells. J Korean Soc Food Sci Nutr. 2004;33:633-40.
2. Cui Y, Kim DS, Park KC. Antioxidant effect of Inonutus obliquus. J Ethnopharmacol. 2005;96:79-85.
3. Jarosz A, Skórska M, Rzymowska J, Kochmanska-Rdest J, Malarczyk E. Effect of the extracts from fungus Inonotus obliquus on catalase level on HeLa and nocardia cells. Acta Biochim Polonica. 1990;37:149-51.
4. Kahlos K, Kangas L, Hiltunen R. Antitumor activity of some compounds and fractions from an n-hexane extract of Inonotus obliquus. Acta Pharmaceut Fennica. 1987;96:33-40.
5. Kim YO, Han SB, Lee HW, Ahn HJ, Yoon YD, Jung JK, Kim HM, Shin CS. Immuno-stimulating effect of the endo-polysaccharide produced by submerged culture of Inonotus obliquus. Life Sci. 2005;77:2438-56.
6. Kim YO, Park HW, Kim JH, Lee JY, Moon SH, Shin CS. Anti-cancer effect and structural characterization of endo-polysaccharide from cultivated mycelia of Inonotus obliquus. Life Sci. 2006;79:72-80.
7. Mizuno T. The extraction and development of antitumor active polysaccharides from medicinal mushrooms in Japan. Int J Med Mushr. 1999;1: 9-29.
8. Mizuno T, Zhuang C, Abe K, Okamoto H, Kiho T, Ukai S, Leclerc S, Meijer L. Antitumor and hypoglycemic activities of polysaccharides from the sclerotia and mycelia of Inonotus obliquus (Per.:Fr.) Pil. (Aphyllophoromycetideae). Int J Med Mushr. 1999;1:301-16.
9. Reid DA. Inonotus obliquus (Pers. ex Fr.) Pilat in Britain. Trans Brit Mycol Soc. 1976;67:329-32.
10. Saar M. Fungi in Khanty folk medicine. J Ethnopharmacol. 1991;31:175-9.
11. Wasser SP. Medicinal mushroom science: history, current status, future trends, and unsolved problems. Int J Med Mushr. 2010;12:1-16.
12. Ichimura T, Otake T, Mori H, Maruyama S. HIV-1 protease inhibition and anti-HIV effect of natural and synthetic watersoluble lignin-like substances. Biosci Biotechnol Biochem. 1999;63:2202-4.
13. Wasser SP, Weis AL. Medicinal properties of substances occurring in higher Basidiomycetes mushrooms: current perspectives (review). Int J Med Mushr. 1999;1:31-62.
14. Park MY, Won HJ, Kim YH, Choi JW, Park HJ, Lee KT. In vivo and in vitro anti-inflammatory and antinociceptive effects of the methanol extract of Inonotus obliquus. J Ethnopharmacol. 2005;101:120-8.
15. Mizuno T, Ando M, Sugie R, Ito H, Shimura K, Sumiya T, Matsuura A. Antitumor activity of some polysaccharides isolated from an edible mushroom, Ningyotake, the fruiting body and the cultured mycelium of Polyporus confluens. Biosci Biotechnol Biochem. 1992;56:34-41.
16. Song HS, Lee JL, Kim SK, Moon WK, Kim DW, Kim YS, Moon KY. Downregulatory effect of AGI-1120 (α-Glucosidase inhibitor) and Chaga mushroom (Inonotus obliquus) on cellular NF-kB activation and their antioxidant activity. Korean J Pharmacognosy. 2004;35:92-7.
17. Kahlos K. Antifungal activity of cysteine, its effect on C-21 oxygenated lanosterol derivatives and other lipid in Inonotus obliquus, in vitro. Appl Microbiol Biotechnol. 1994;3:339-85.
18. Nakajima Y, Sato Y, Konishi T. Antioxidant small phenolic ingredients in Inonotus obliquus (Persoon) Pilat (Chaga). Chem Pharmaceut Bull. 2007;55:1222-6.
19. Kukulyanskaya TA, Kurchenko NV, Kurchenko VP, Babitskaya VG. Physicochemical properties of melanins produced by the sterile form of Inonotus obliquus ("Chagi") in natural and cultivated fungus. Appl Biochem Microbiol. 2002;38:58-61.
20. Song YS, Kim SH, Sa JH, Jin C, Lim CJ, Park EH. Antiangiogenic, antioxidant and xanthine oxidase inhibition activities of the mushroom Phellinus linteus. J Ethnopharmacol. 2003;88:113-6.
21. Youn MJ, Kim JK, Park SY, Kim Y, Kim SJ, Lee JS, Chai KY, Kim HJ, Cui MX, So HS, Kim KY, Park R. Chaga mushroom (Inonotus obliquus) induces G0/ G1 arrest and apoptosis in human hepatoma HepG2 cells. World J Gastroenterol. 2008;14:511-7.
22. Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M, Nuñez G, Krammer PH, Peter ME, Debatin KM. Betulinic acid triggers CD95 (APO-1/ Fas)-and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res. 1997;57:4956-64.
23. Rzeski W, Stepulak A, Szymański M, Sifringer M, Kaczor J, Wejksza K, Zdzisińska B, Kandefer-Szerszeń M. Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells. Naunyn-Schmiedeberg's Arch Pharmacol. 2006;374:11-20.
24. Noda Y, Kaiya, T, Kohda K, Kawazoe Y. Enhanced cytotoxicity of some triterpenes toward leukemia L1210 cells cultured in low pH media: possibility of a new mode of cell killing. Chem Pharmaceut Bull. 1997;45:1665-70.
25. Sung B, Pandey MK, Nakajima Y, Nishida H, Konishi T, Chaturvedi MM, Aggarwal BB. Identification of a novel blocker of Ikappa Balpha kinase activation that enhances apoptosis and inhibits proliferation and invasion by suppressing nuclear factor-kappaB. Mol Cancer Therapeut. 2008;7:191-201.
26. Mazurkiewicz W, Rydel K, Pogocki D, Lemieszek MK, Langner E, Rzeski W. The separation of an aqueous extract Inonotus obliquus (chaga). A novel look at the efficiency of its influence on proliferation of A549 human lung carcinoma cells. Acta Pol Pharm. 2010;67:397-406.
27. Wejksza K, Rzeski W, Parada-Turska J, Zdzisinska B, Rejdak R, Kocki T, Okuno E, Kandefer-Szerszen M, Zrenner E, Turski WA. Kynurenic acid production in cultured bovine aortic endothelial cells. Homocysteine is a potent inhibitor. Naunyn-Schmiedeberg's Arch Pharmacol. 2004;369:300-4.
28. Rzeski W, Matysiak J, Kandefer-Szerszeń M. Anticancer, neuroprotective activities and computational studies of 2-amino-1,3,4-thiadiazole based compound. Bioorg Med Chem. 2007;15:3201-7.
29. Lindequist U, Niedermeyer THJ, Jülich WD. The pharmacological potential of mushrooms. Evid Based Complement Alternat Med. 2005;2:285-99.
30. Rzymowska J. The effect of aqueous extracts from Inonotus obliquus on the mitotic index and enzyme activities. Boll Chim Farm. 1998;137:13-5.
31. Ożarowski A. Huba zwalcza raka. Świat to Apteka. 2000;4:49.
32. Anioł-Kwiatkowska J. Brzoza w weterynarii. Wiadomości Zielarskie. 1994;4:19-20.
33. Pollak M. Insulin-like growth factor physiology and cancer risk. Eur J Cancer. 2000;36:1224-8.
34. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004;363:1346-53.
35. Yang SY, Sales KM, Fuller BJ, Seifalian AM, Winslet MC. Inducing apoptosis of human colon cancer cells by an IGF-I D domain analogue peptide. Mol Cancer. 2008;8:7-17.
36. Lahm H, Amstad P, Wyniger J, Yilmaz A, Fischer JR, Schreyer M, Givel JC. Blockade of the insulinlike growth-factor-I receptor inhibits growth of human colorectal cancer cells: evidence of a functional IGF-II-mediated autocrine loop. Int J Cancer. 1994;58:452-9.
37. Giovannucci E. Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res. 2003;35: 694-704.